Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dex-Fib
NCT04655144Phase 3Completed
- Sponsor
- University of Miami
- Start
- Jan 2021
- Primary completion
- Dec 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in post-embolization syndrome (PES), pain, sponsored by University of Miami. Started Jan 2021; status: completed.
02
Drugs
dexamethasone
03
Conditions
post-embolization syndrome (PES)pain
Beyond the preview
Go deeper on NCT04655144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04655144.